{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:24:04Z","timestamp":1760300644886,"version":"3.37.3"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T00:00:00Z","timestamp":1637280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>The impact of mitral valve geometry on outcomes after MitraClip treatment in secondary mitral regurgitation (MR) has not been examined. We therefore sought to evaluate the association between mitral valve geometry and outcomes of patients with heart failure (HF) and secondary MR treated with guideline-directed medical therapy (GDMT) and MitraClip.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>Mitral valve geometry was assessed from the baseline echocardiograms in 614 patients from the COAPT trial. The primary endpoint for the present study was the composite of all-cause mortality or HF hospitalization (HFH) within 2 years. Effect of treatment arm (MitraClip plus maximally tolerated GDMT vs. GDMT alone) on outcomes according to baseline variables was assessed. Among 29 baseline mitral valve echocardiographic parameters, increasing anteroposterior mitral annular diameter was the only independent predictor of the composite endpoint of all-cause mortality or HFH [adjusted hazard ratio (aHR) per cm 1.49; P = 0.04]. The effective regurgitant orifice area (EROA) was independently associated with all-cause mortality alone (aHR per cm2 2.97; P = 0.04) but not with HFH, whereas increasing anteroposterior mitral annular diameter was independently associated with HFH alone (aHR per cm 1.85; P = 0.005) but not all-cause mortality. Other mitral valve morphologic parameters were unrelated to outcomes. MitraClip reduced HFH and mortality independent of anteroposterior mitral annular diameter and EROA (Pinteraction = 0.77 and 0.27, respectively).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>In patients with HF and severe secondary MR, a large anteroposterior mitral annular diameter and greater EROA were the strongest echocardiographic predictors of HFH and death in patients treated with GDMT alone and with the MitraClip.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjci\/jeab224","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T19:11:06Z","timestamp":1635361866000},"page":"1540-1551","source":"Crossref","is-referenced-by-count":9,"title":["Prognostic implications of mitral valve geometry in patients with secondary mitral regurgitation: the COAPT trial"],"prefix":"10.1093","volume":"23","author":[{"given":"Farnaz","family":"Namazi","sequence":"first","affiliation":[{"name":"Department of Cardiology, Leiden University Medical Center , Albinusdreef 2, 2300 RC Leiden , The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7058-3940","authenticated-orcid":false,"given":"Victoria","family":"Delgado","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Leiden University Medical Center , Albinusdreef 2, 2300 RC Leiden , The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan Milhorini","family":"Pio","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Leiden University Medical Center , Albinusdreef 2, 2300 RC Leiden , The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Ajmone Marsan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Leiden University Medical Center , Albinusdreef 2, 2300 RC Leiden , The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico M","family":"Asch","sequence":"additional","affiliation":[{"name":"MedStar Health Research Institute , Washington, DC , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3944-9297","authenticated-orcid":false,"given":"Diego","family":"Medvedofsky","sequence":"additional","affiliation":[{"name":"MedStar Health Research Institute , Washington, DC , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil J","family":"Weissman","sequence":"additional","affiliation":[{"name":"MedStar Health Research Institute , Washington, DC , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhipeng","family":"Zhou","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Foundation , New York, NY , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4155-4451","authenticated-orcid":false,"given":"Bjorn","family":"Redfors","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Foundation , New York, NY , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JoAnn","family":"Lindenfeld","sequence":"additional","affiliation":[{"name":"Vanderbilt Heart and Vascular Institute , Nashville, TN , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William T","family":"Abraham","sequence":"additional","affiliation":[{"name":"The Ohio State University Medical Center , Columbus, OH , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J","family":"Mack","sequence":"additional","affiliation":[{"name":"Baylor Scott & White Health , Plano, TX , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3416-8210","authenticated-orcid":false,"given":"Gregg W","family":"Stone","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Foundation , New York, NY , USA"},{"name":"The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai , New York, NY , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7368-0500","authenticated-orcid":false,"given":"Jeroen J","family":"Bax","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Leiden University Medical Center , Albinusdreef 2, 2300 RC Leiden , The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,11,19]]},"reference":[{"key":"2022102020372798100_jeab224-B1","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS Guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"key":"2022102020372798100_jeab224-B2","doi-asserted-by":"crossref","first-page":"e1159","DOI":"10.1161\/CIR.0000000000000503","article-title":"2017 AHA\/ACC focused update of the 2014 AHA\/ACC Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"135","author":"Nishimura","year":"2017","journal-title":"Circulation"},{"key":"2022102020372798100_jeab224-B3","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"2022102020372798100_jeab224-B4","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","article-title":"2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA Guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America","volume":"70","author":"Yancy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2022102020372798100_jeab224-B5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.amjcard.2018.09.020","article-title":"Effect of functional mitral regurgitation on outcome in patients receiving cardiac resynchronization therapy for heart failure","volume":"123","author":"van der Bijl","year":"2019","journal-title":"Am J Cardiol"},{"key":"2022102020372798100_jeab224-B6","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.jacc.2007.08.019","article-title":"Acute effects of initiation and withdrawal of cardiac resynchronization therapy on papillary muscle dyssynchrony and mitral regurgitation","volume":"50","author":"Ypenburg","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2022102020372798100_jeab224-B7","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/heartjnl-2017-312002","article-title":"Secondary mitral regurgitation (part 2): deliberations on mitral surgery and transcatheter repair","volume":"104","author":"Gaasch","year":"2018","journal-title":"Heart"},{"key":"2022102020372798100_jeab224-B8","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/CIRCULATIONAHA.119.039612","article-title":"Contrasting effects of pharmacological, procedural, and surgical interventions on proportionate and disproportionate functional mitral regurgitation in chronic heart failure","volume":"140","author":"Packer","year":"2019","journal-title":"Circulation"},{"key":"2022102020372798100_jeab224-B9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.amjcard.2010.03.042","article-title":"Predictors of mitral regurgitation recurrence in patients with heart failure undergoing mitral valve annuloplasty","volume":"106","author":"Ciarka","year":"2010","journal-title":"Am J Cardiol"},{"key":"2022102020372798100_jeab224-B10","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/CIRCULATIONAHA.106.649236","article-title":"Preoperative posterior leaflet angle accurately predicts outcome after restrictive mitral valve annuloplasty for ischemic mitral regurgitation","volume":"115","author":"Magne","year":"2007","journal-title":"Circulation"},{"key":"2022102020372798100_jeab224-B11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jacc.2010.04.030","article-title":"Anatomy of the mitral valvular complex and its implications for transcatheter interventions for mitral regurgitation","volume":"56","author":"Van Mieghem","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2022102020372798100_jeab224-B12","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/ehjci\/jet060","article-title":"Peri-interventional echo assessment for the MitraClip procedure","volume":"14","author":"Wunderlich","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2022102020372798100_jeab224-B13","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N Engl J Med"},{"key":"2022102020372798100_jeab224-B14","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","article-title":"Percutaneous repair or medical treatment for secondary mitral regurgitation","volume":"379","author":"Obadia","year":"2018","journal-title":"N Engl J Med"},{"key":"2022102020372798100_jeab224-B15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2018.07.021","article-title":"Cardiovascular outcomes assessment of the mitraclip in patients with heart failure and secondary mitral regurgitation: design and rationale of the COAPT trial","volume":"205","author":"Mack","year":"2018","journal-title":"Am Heart J"},{"key":"2022102020372798100_jeab224-B16","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1016\/j.jacc.2019.09.017","article-title":"Echocardiographic outcomes after transcatheter leaflet approximation in patients with secondary mitral regurgitation: the COAPT trial","volume":"74","author":"Asch","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2022102020372798100_jeab224-B17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/ehjci\/jev014","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"16","author":"Lang","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2022102020372798100_jeab224-B18","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.echo.2010.05.010","article-title":"Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography","volume":"23","author":"Rudski","year":"2010","journal-title":"J Am Soc Echocardiogr"},{"key":"2022102020372798100_jeab224-B19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.echo.2017.01.007","article-title":"Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance","volume":"30","author":"Zoghbi","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"key":"2022102020372798100_jeab224-B20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/ejechocard\/jeq031","article-title":"European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease)","volume":"11","author":"Lancellotti","year":"2010","journal-title":"Eur J Echocardiogr"},{"key":"2022102020372798100_jeab224-B21","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/ehjci\/jet105","article-title":"Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging","volume":"14","author":"Lancellotti","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2022102020372798100_jeab224-B22","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/S0735-1097(02)01838-7","article-title":"Isolated annular dilation does not usually cause important functional mitral regurgitation: comparison between patients with lone atrial fibrillation and those with idiopathic or ischemic cardiomyopathy","volume":"39","author":"Otsuji","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"2022102020372798100_jeab224-B23","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/CIRCULATIONAHA.116.025260","article-title":"Exercise dynamics in secondary mitral regurgitation: pathophysiology and therapeutic implications","volume":"135","author":"Bertrand","year":"2017","journal-title":"Circulation"},{"key":"2022102020372798100_jeab224-B24","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.euje.2004.03.001","article-title":"Echocardiographic classification of chronic ischemic mitral regurgitation caused by restricted motion according to tethering pattern","volume":"5","author":"Agricola","year":"2004","journal-title":"Eur J Echocardiogr"},{"key":"2022102020372798100_jeab224-B25","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.amjcard.2018.06.036","article-title":"Comprehensive assessment of mitral valve geometry and cardiac remodeling with 3-dimensional echocardiography after percutaneous mitral valve repair","volume":"122","author":"Mantegazza","year":"2018","journal-title":"Am J Cardiol"},{"key":"2022102020372798100_jeab224-B26","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMoa1602003","article-title":"Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation","volume":"374","author":"Michler","year":"2016","journal-title":"N Engl J Med"},{"key":"2022102020372798100_jeab224-B27","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jacc.2020.07.010","article-title":"Predictors of clinical response to transcatheter reduction of secondary mitral regurgitation: the COAPT trial","volume":"76","author":"Grayburn","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2022102020372798100_jeab224-B28","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jcin.2013.12.198","article-title":"MitraClip therapy in surgical high-risk patients: identification of echocardiographic variables affecting acute procedural outcome","volume":"7","author":"Lubos","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"2022102020372798100_jeab224-B29","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1002\/ejhf.1774","article-title":"The impact of residual mitral regurgitation after MitraClip therapy in functional mitral regurgitation","volume":"22","author":"Reichart","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"2022102020372798100_jeab224-B30","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.jcin.2019.09.014","article-title":"Impact of the leaflet-to-annulus index on residual mitral regurgitation in patients undergoing edge-to-edge mitral repair","volume":"12","author":"Tabata","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"2022102020372798100_jeab224-B31","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1009355","article-title":"Percutaneous repair or surgery for mitral regurgitation","volume":"364","author":"Feldman","year":"2011","journal-title":"N Engl J Med"},{"key":"2022102020372798100_jeab224-B32","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1016\/j.jacc.2019.09.014","article-title":"Operator experience and outcomes of transcatheter mitral valve repair in the United States","volume":"74","author":"Chhatriwalla","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2022102020372798100_jeab224-B33","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1136\/heartjnl-2012-302527","article-title":"Role of real-time three dimensional transoesophageal echocardiography as guidance imaging modality during catheter based edge-to-edge mitral valve repair","volume":"99","author":"Faletra","year":"2013","journal-title":"Heart"}],"container-title":["European Heart Journal - Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/23\/11\/1540\/46583493\/jeab224.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/23\/11\/1540\/46583493\/jeab224.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T20:41:45Z","timestamp":1666298505000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article\/23\/11\/1540\/6432023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,19]]},"references-count":33,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11,19]]},"published-print":{"date-parts":[[2022,10,20]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjci\/jeab224","relation":{},"ISSN":["2047-2404","2047-2412"],"issn-type":[{"type":"print","value":"2047-2404"},{"type":"electronic","value":"2047-2412"}],"subject":[],"published-other":{"date-parts":[[2022,11,1]]},"published":{"date-parts":[[2021,11,19]]}}}